IPQ Inside the global regulatory dialogue

Industry Experience with Autologous Cell Therapies Underscores Need for Upfront Planning on Integrating Facility Design, Operations, and Supply Lines

Nov 8th, 2019

Please Log in to print the full article

Poor Planning Leads to Bottlenecks Vernon began his presentation by outlining the challenges that companies face in building the capacity needed to meet growing demand for autologous cell products, noting the ways that autologous cell...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2020 IPQ Publications